Genetic screening: ethical issues - Nuffield Council on Bioethics
Genetic screening: ethical issues - Nuffield Council on Bioethics
Genetic screening: ethical issues - Nuffield Council on Bioethics
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
108<br />
C<strong>on</strong>genital hypothyroidism<br />
Mode of inheritance : usually not inherited - about 5-10% of cases due to a<br />
known genetic defect<br />
Abnormal development or functi<strong>on</strong> of the thyroid gland resulting in lack of producti<strong>on</strong><br />
of thyroid horm<strong>on</strong>e (thyroxine) occurs in about 1 in 4,000 babies in the UK. The baby<br />
is usually normal at birth because the mother’s thyroxine has been able to pass to the<br />
baby. Unless treatment with thyroxine is started within the first few weeks of life,<br />
growth and mental development will be delayed. Screening is carried out by measuring<br />
specific horm<strong>on</strong>es in the blood taken from the baby at around the end of the first week<br />
(the same blood sample as used for PKU - see later).<br />
Cystic fibrosis<br />
Mode of inheritance : recessive<br />
Cystic fibrosis (CF) is a serious inherited disease affecting the lungs and digestive<br />
system of babies, children and young adults. People with CF have sticky mucus in<br />
their lungs and are particularly pr<strong>on</strong>e to chest infecti<strong>on</strong>s. They also have difficulty in<br />
digesting foods, especially fatty foods, and may later develop liver problems.<br />
Treatment (antibiotics, physiotherapy, digestive enzymes) can greatly help but does not<br />
cure the c<strong>on</strong>diti<strong>on</strong>. The average life expectancy for a pers<strong>on</strong> with CF is about 20-30<br />
years. The disorder is inherited and the change in the gene resp<strong>on</strong>sible for about 85%<br />
of the cases can now be detected. For the disease to develop, a defective gene must<br />
be inherited from each parent. Parents who have <strong>on</strong>ly <strong>on</strong>e of a pair of defective genes<br />
are known as carriers and are themselves completely healthy. About 1 in 20 of the<br />
white populati<strong>on</strong> in the UK are carriers of the gene; the disease occurs in about 1 in<br />
2,000 babies born. If both parents are carriers, the risk of any baby having the disease<br />
is 1 in 4.<br />
Down’s syndrome<br />
Mode of inheritance : usually not inherited<br />
The disorder, which is genetic but usually not inherited, affects about 1 in 600 babies<br />
born overall, although the risk of having a child with Down’s syndrome rises sharply<br />
when the mother is over 35 years of age.<br />
The vast majority of individuals with Down’s syndrome have an extra copy of<br />
chromosome 21, are born with specific physical characteristics and have severe<br />
learning disabilities. A very small percentage are inherited due to a translocati<strong>on</strong>.<br />
Duchenne muscular dystrophy (DMD)<br />
Mode of inheritance : X-linked<br />
Duchenne muscular dystrophy is a serious progressive disease of muscles affecting<br />
about <strong>on</strong>e in 3,500 newborn boys. There are no signs of disease at birth, and affected<br />
boys develop and grow normally until around 18 m<strong>on</strong>ths of age. From the ages of 7<br />
to 12, affected boys become wheelchair bound. Death from chest infecti<strong>on</strong> or heart<br />
failure usually occurs by the early 20s or before.